A new study has found that racial inequalities appear to exist where access to dementia drugs is concerned, with Asian people with the disease 14 per cent less likely than their white counterparts to be prescribed anti-dementia medication when they could have been...

In a move to tackle concerns over the impact of pharmaceuticals on the environment, the One Health Breakthrough Partnership has been set up to investigate the scale of the problem in Scotland. It will also research ways into creating ‘greener’ pharmaceuticals, as an...

The European Medicines Agency (EMA) has published a roundup of its activity in 2019, revealing that last year it recommended a total of 66 human medications for marketing authorisation.  Once this authorisation is granted, these medicines can be made available to...

A partnership between Cancer Research UK and Vaccitech Oncology Limited (VOLT) has brought forth an announcement for the first in-human trials for new lung cancer immunotherapy, introducing innovative immunotherputic vaccine strategies to patients with the condition....

A new vaccine that could help prevent the onset of dementia is due to start human trials in the next 18 to 20 months, with the drug set to enter the market in five to ten years if the trials are successful. Researchers at Flinders University in Australia, with support...

The Association of the British Pharmaceutical Industry (ABPI) has launched its General Election 2020 Manifesto for Medicine, calling on the next government to ensure that it builds on the UK’s life science industry to help improve the health of NHS patients....

Demand for abortion medication from internet-based sources is highest among those US states that have restrictive policies in place, new research has revealed, indicating that 76 per cent of requests come from those living in states like Mississippi, which has the...